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Vitamin D deficiency and course of frailty in a depressed older population.  
 
ABSTRACT 
Objective - To study the association between vitamin D levels and frailty, its 
components and its course in a depressed sample. 
Methods – Baseline and two-year follow-up data from the depressed sample of the 
Netherlands Study of Depression in Older persons (NESDO), a prospective 
observational cohort study, were analyzed. The 378 participants were aged 60-93, and 
had a diagnosis of depression according to DSM-IV criteria. Frailty was defined 
according to Fried’s physical phenotype. 25-OH vitamin D measurement was 
performed by liquid chromatography – tandem mass spectrometry. Linear and logistic 
regression analyses were performed, adjusted for covariates.  
Results - A cross-sectional association between higher vitamin D levels and lower 
prevalence of frailty was demonstrated (OR 0.64 [95%-CI 0.45 – 0.90], p=.010). 
Among non-frail depressed patients, higher vitamin D levels predicted a lower 
incidence of frailty (OR 0.51 [95%-CI 0.26 – 1.00], p=.050). Surprisingly, higher 
vitamin D levels predicted the persistence of frailty among frail depressed patients 
(OR 2.82 [95%-CI 1.23 – 6.49], p=.015). 
Conclusions - In a depressed population, higher vitamin D levels were associated with 
a lower prevalence and incidence of frailty. Future studies should examine whether the 
favorable effect of low vitamin D levels on the course of frailty can be explained by 
confounding or whether unknown pathophysiological mechanisms may exert 
protective effects.  
 




With one billion vitamin D deficient people (Holick, 2007), vitamin D deficiency is a major 
public health problem worldwide (Palacios & Gonzalez, 2014). It is especially common 
among older persons, mainly due to lack of sunlight exposure, decreased synthesis of vitamin 
D in the skin and loss of renal function with aging (Gallagher, 2014).   
The role of vitamin D in calcium and phosphate metabolism is well-known. Recently, 
knowledge about its extra-skeletal effects has been expanding. Vitamin D receptors are 
widely distributed in the body, and have been, among others, localized in the skeletal muscles 
(Bisschoff et al., 2001) and the brain (Eyles, Smith, Kinobe, Hewison, & McGrath, 2005). 
Epidemiological studies have shown associations between hypovitaminosis D and several 
conditions, such as depression (Anglin, Samaan, Walter, & McDonald, 2013; Oude Voshaar 
et al., 2014) and physical frailty (Chang, Chan, Kuo, Hsiung, & Chen, 2010; Ensrud et al, 
2011; Hirani et al., 2013; Pabst et al., 2015; Shardell et al., 2009; Smit et al., 2012; Wilhelm-
Leen, Hall, Deboer, & Chertow, 2010). 
A key feature of frailty, and potential link with vitamin D deficiency, is sarcopenia, 
the loss of skeletal muscle (Fried et al., 2001).  In older persons, a consistent relationship 
between hypovitaminosis D and muscle dysfunction has been demonstrated (Halfon, Phan, & 
Teta, 2015), as well as a positive effect of vitamin D supplementation on balance and muscle 
strength (Muir & Montero-Odasso, 2011). While vitamin D indirectly affects muscle function 
by its impact on the calcium and phosphate balance, its direct effects are supposed to 
stimulate synthesis of proteins involved in contractility, proliferation and distribution of 
muscle cells (Ceglia & Harris, 2013).   
Yet, frailty is more multifaceted than sarcopenia alone (Morley et al., 2013). Frailty 
has been defined as a medical syndrome, with multiple causes and contributors, characterized 
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by diminished strength, endurance and reduced physiologic function that increases an 
individual’s vulnerability for developing increased dependency or death (Morley et al., 2013).  
Meta-analysis of longitudinal population-based studies showed increased odds of low 
vitamin D levels on incident frailty (Zhou et al., 2016). Although frailty-experts consider 
vitamin D supplements useful for frail persons with vitamin D deficiency (Morley et al., 
2013), intervention studies are currently lacking (Bruyère, Cavalier, Buckinx, & Reginster, 
2017).  
In spite of a consistently found association between low vitamin D levels and 
depression (Anglin et al., 2013), the potential causal mechanism is still debated. Recently, it 
was demonstrated that vitamin D levels did not predict the course of depression in a sample of 
older persons. Instead, lower vitamin D levels were associated with mortality (Van den Berg 
et al., 2016). Since frailty and late-life depression have been reciprocally related in the 
population (Collard et al., 2015b; Lakey et al., 2012), frailty might be a somatic pathway 
underlying this association.  
The present study aims to evaluate the cross-sectional and longitudinal association of 
vitamin D and frailty in a cohort of depressed older persons.  
 
Materials and methods  
Sample 
Data were obtained from the Netherlands Study of Depression in Older persons (NESDO), a 
cohort study designed to examine the determinants, course and consequences of late-life 
depression (Comijs et al., 2011; Comijs et al., 2015). 
In total, 378 depressed patients and 132 non-depressed controls, aged 60 to 93, were 
recruited from mental health institutions and general practitioners between 2007 and 2010. 
Depressed patients had a diagnosis of major depressive disorder (95.0%) and/or dysthymia 
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(26.5%) in the previous six months, or minor depression (5.6%) in the last month, according 
to the Diagnostic and Statistical Manual of Mental Disorders (DSM-IV-TR; American 
Psychiatric Association, 2000) and assessed by the Composite International Diagnostic 
Interview (CIDI; WHO version 2.1, life time version). Controls had no lifetime diagnosis of 
depression. Subjects with a severe primary disorder, such as a psychotic disorder, a primary 
diagnosis of dementia, or suspected for dementia according to their clinician, as well as 
subjects with a Mini Mental State Examination (MMSE; Folstein MF, Folstein, & McHugh, 
1975) score <18/30 or insufficient command of the Dutch language were excluded. The cut-
off on the MMSE was lowered from 24 to 18 in order to be able include the more severely 
depressed patients with transient cognitive decline due to their depressed state. This was 
considered possible, as clinicians experienced in the diagnostics of dementia had to exclude 
all patients they suspected from an underlying dementia. 
At baseline, data were gathered about mental health outcomes, demographic 
characteristics and psychosocial, biological, cognitive and genetic determinants. Measures 
subject to change were evaluated again at follow-up. Interviews were performed by trained 
research assistants and audiotaped regularly to control for quality. If necessary, participants 
were visited at home. The ethical review boards of the participating centers approved the 
study. All participants provided informed consent. 
Of the 378 depressed patients, 352 with complete data on frailty and vitamin D were 
included in the cross-sectional analyses. Excluded persons (n=26) were lower educated (8.5 
vs. 10.6 years, t=2.98, df=376, p=.003), more often frail (63.6% vs. 29.0%, 2=6.10, df=1, 
p=.014) and scored higher on the Inventory of Depressive Symptomatology (IDS-SR; Rush, 
Gullion, Basco, Jarrett, & Trivedi, 1996): 36.7 vs. 29.7 points (interpretation: 0-13 not 
depressed; 14-25 mildly depressed; 26-38 moderately depressed; ≥39 severely depressed); t= 
-2.51, df=371, p=.012 than participants. Since actual vitamin D levels were available, vitamin 
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D supplementation was not taken into account in cross-sectional analyses. Nonetheless, 
sensitivity analyses without supplementation users (n=14) were performed. 
At two-year follow-up, 285 initially-depressed patients still participated, 26 had died 
and 67 were lost to follow-up for other reasons. Participants with missing frailty data (n=30) 
or baseline vitamin D data (n=5), and users of vitamin D supplementation (n=18) were 
excluded, leaving a sample of 235 persons for longitudinal analyses. Compared to 
participants, excluded persons (n=143) were less educated (9.7 vs. 10.9 years, t=3.16, df=376, 
p=.002), had more chronic diseases (2.8 vs. 2.4, t=-2,29, df=259,2, p=.023), used less alcohol 
(Alcohol Use Disorders Identification Test (AUDIT; Babor, Kranzler, & Lauerman, 1989) 
sum score 2.2 vs. 2.8 (range 0-40); Mann-Whitney U p=.021), were more often smokers 
(32.2% vs. 23.0%; 2=4.10, df=1, p=.043) and more often frail at baseline (32.9% vs. 26.4%, 
2=4.21, df=1, p=.040). For 22 of 26 deceased persons complete baseline frailty and vitamin 




Vitamin D levels 
Serum 25-(OH) vitamin D3 levels were measured at baseline using isotope dilution-online 
solid-phase extraction liquid chromatography–tandem mass spectrometry, as described 
previously (Doorenbos et al., 2012).  
Method characteristics are the following: limit of quantitation 4.0 nmol/l, intra-assay 
coefficient of variation <7.2% and inter-assay coefficient of variation <14.1% for three 
concentrations between 20 and 150 nmol/l; recovery ranges from 93 to 98% and linearity was 
acceptable (r2 = 0.9972). The accuracy of 25-(OH) vitamin D3 levels was established using 
(the National Institute of Standards and Technology, Gaithersburg, MD, USA) reference 
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material to establish true values for calibration standards. Calibration standards, quality 
control samples and patient samples were stable for 6 days at 6˚C (coefficient of variation < 
11%). Samples were stable for at least three freeze-thaw cycles (coefficient of variation <3%). 
The optimal 25-(OH) vitamin D level is thought to be between 75 and 100 nmol/l, above 
which point studies found parathyroid hormone levels (inversely related to vitamin D) 
beginning to level off (Holick, 2007).  
Frailty 
According to Fried’s physical frailty phenotype, frailty was defined as the presence of ≥ 3 out 
of 5 dichotomous criteria: exhaustion, weakness, slow walking speed, inactivity, and 
unintended weight loss (Fried et al., 2001). These criteria were operationalized as follows 
(Collard, Comijs, Naarding, & Oude Voshaar, 2014).  
 Weakness: low handgrip strength, measured by two squeezes with the dominant hand in a 
dynamometer. Cut-off values depended on body mass index and varied between 29-32 kg 
for men and 17-21 kg for women (Fried et al., 2001).  
 Unintended weight loss: positive answer to the CIDI question about unintended weight 
loss (≥ 1 kg/week, for ≥ 2 consecutive weeks), or a body mass index (BMI) < 18.5 kg/m2.   
 Slowness: time on a six-meter walking test ≥ 8 seconds for men ≥ 173 cm or women ≥ 159 
cm height, or ≥ 9 seconds for men < 173 cm and women < 159 cm height.  
 Low physical activity:  no daily activities such as walking or gardening, and the 
performance of sports less than once a week, assessed with the International Physical 
Activity Questionnaire (IPAQ; Craig et al., 2003) 
 Exhaustion: a score of 3 or 4 out of 4 points on one or both of the IDS-SR (Rush et al., 
1996) questions about energy level and leaden paralysis / physical energy.  
 
The primary outcome measures were incident frailty (the presence of frailty at follow-up 
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in a person without frailty at baseline) and persistent frailty (the presence of frailty at follow 
up in a person with frailty at baseline). Secondary outcome measures were the continuous 
dimensions underlying the individual frailty components of the Fried model, i.e. highest value 
for handgrip strength in kilograms (weakness), weight in kilograms (weight loss), six-meter 
walking time in seconds (slowness), number of Metabolic Equivalent of Task (MET)- 
minutes per week (Craig et al., 2003) (physical inactivity) and sum scores of the two IDS-SR 




Based on their association with vitamin D level, depression or frailty, we a priori selected age, 
gender, years of education, astronomical season of blood withdrawal, smoking, use of 
alcohol, cognitive functioning, number of chronic diseases, renal function and depression 
symptom score as covariates (Collard et al., 2015a; Oude Voshaar et al., 2014).  
Use of alcohol was assessed by AUDIT sum scores (Babor, Kranzler, & Lauerman, 
1989). The number of chronic diseases was assessed by means of self-report questions, an 
accurate method when compared to data from general practitioners (Kriegsman, Penninx, van 
Eijk, Boeke, & Deeg, 1996). The MMSE was used to assess global cognitive functioning 
(range 0–30) (Folstein et al., 1975).  Glomerular filtration rates (GFR) were estimated by the 
Chronic Kidney Disease Epidemiology Collaboration (CKD-EPI; Levey et al., 2009) formula 
to assess renal function. Severity of depressive symptomatology was assessed by IDS-SR 
(Rush et al., 1996) scores.  
 
Statistical analysis 
Vitamin D levels were standardized using Z-scores. The different groups, based on frailty 
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status, were compared with T-tests, ANOVA and chi-square tests. Non-parametric tests were 
performed in case of a skewed distribution. 
The cross-sectional and longitudinal association between vitamin D and frailty was 
analyzed using logistic regression, with the presence of frailty (yes/no) as the dependent 
parameter. The association between vitamin D level and the individual frailty components 
was analyzed by linear regression. At follow-up, frailty components were adjusted for their 
own baseline value, in order to assess their course. Continuous values for walking speed were 
log transformed to achieve a normal distribution.  
Analyses were adjusted for all covariates. Missing covariates were imputed with the 
group mean (IDS score n = 2, AUDIT sum score n = 2, smoking status n = 2). 
Analyses were performed using the Statistical Package for the Social Sciences (SPSS) 
version 22.0.0.1. (IBM Corp., NY, USA). All statistical tests were two-sided, p-values at or 





At baseline, 102 of 352 participants (29.0%) were frail. Persons with frailty were on average 
older, had had less years of education, used less alcohol, had more chronic diseases, higher 
severity of depression, worse cognitive functioning and lower vitamin D levels than non-frail 
persons (see Table 1).  
Lower vitamin D levels were associated with the presence of frailty. Regarding the 
individual frailty components, higher vitamin D levels were associated with more physical 
activity and greater grip strength (see Table 2). Exclusion of users of vitamin D 
supplementation (n=14) neither altered the association with frailty (adjusted OR for frailty 
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0.64 [95%-CI 0.45 – 0.92], p=.015) nor the association with the individual frailty components 
(results not shown).  
 
 -- Table 1 and 2 -- 
 
Longitudinal analyses. 
At two-year follow-up, 173 of the 250 participants without frailty at baseline, participated 
again. Of those, 21 (12,1%) had become frail.  
Compared to the persistently non-frail, participants with incident frailty were older 
(mean 74.0 (standard deviation (s.d.) 7.8) vs. 68.6 (s.d. 6.5) years, p=.001), had more chronic 
diseases (mean 2.9 (s.d. 1.6) vs. 2.1 (s.d. 1.4), p=.011) and lower scores for cognitive 
functioning (median 27.0 (interquartile range (IQR) 3) vs 28.0 (IQR 2), p=.002). Remission 
of depression at follow-up did not differ between the persistently non-frail (n=86; 56.6%) and 
the incident frail (n=9; 42.9%, p=.236). There were no significant differences with respect to 
the other variables (results not shown).  
As shown in Table 3, a significant association between higher baseline vitamin D 
levels and lower odds for incident frailty at two-year follow-up was found. When deceased 
persons were considered incident frail as well, this association was even stronger. Regarding 
the individual frailty components, only the association between higher baseline vitamin D 
levels and more physical activity at follow-up was significant.  
 
-- Table 3 --  
 
Of the 102 baseline-frail persons, 62 participated again at two-year follow-up. Frailty had 
remitted in 31 persons (50%).  Participants with persistent frailty were older (mean 75.9 (s.d. 
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8.6) vs 70.5 years (s.d. 7.1), p=.009) and had less renal function at baseline (mean GFR 68.1 
ml/min/1.73m2 (s.d. 17.4) vs 77.7 ml/min/1.73m2 (s.d. 14.6), p=.022) compared to persons 
with remission of frailty. Among persistently frail persons, depression had remitted less often 
(n=8, 25.8%) than in persons with remitted frailty (n=21; 67.7%; p=.001). The other variables 
did not differ significantly (results not shown).  
In fully adjusted analyses (see Table 4), higher vitamin D levels were associated with 
higher odds of persistent frailty at follow-up. As depression remitted significantly less often in 
persistently frail patients, we checked post-hoc the interaction between baseline vitamin D 
level and the presence of depression at two-year follow-up. This interaction term, however, 
was not significant. 
Furthermore, the impact of vitamin D levels on persistence of frailty was neither 
present in the univariate analyses, nor in the sensitivity analyses. A stepwise procedure 
demonstrated that adjustment for use of alcohol amplified the effect of higher vitamin D 
levels on persistence of frailty the most. Regarding the individual frailty components, higher 
vitamin D levels were associated with increased exhaustion.  For the other frailty components, 
no significant association with vitamin D levels was found. 
 




In a cohort of depressed, older persons, lower vitamin D levels were cross-sectionally 
associated with greater odds of prevalent frailty, which is mainly driven by the components 
physical inactivity and weakness. In persons without frailty at baseline, lower vitamin D 
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levels doubled the odds of incident frailty and were associated with a further decrease of 
physical activity at two-year follow-up.  
In the subgroup of baseline-frail participants, frailty had remitted in 31 of 62 
participants (50%) two years later. Remarkably, higher vitamin D levels were associated with 
persistent frailty over time, irrespective of the fact that improvement of frailty was 
significantly associated with remission of depression.  
 
Comparison to the literature  
Our cross-sectional findings are in line with previous studies, reporting associations between 
lowest vitamin D levels and presence of frailty according to the Fried phenotype (Chang et 
al., 2010; Ensrud et al., 2011; Fried et al., 2001; Hirani et al., 2013; Semba et al., 2006; 
Shardell et al., 2009; Tajar et al., 2013).  
Regarding the individual frailty components, we found that lower vitamin D levels were 
associated with weakness and physical inactivity, while other studies have demonstrated 
associations solely with weakness (Ensrud et al., 2011) or with all frailty components except 
weight loss (Hirani et al., 2013; Tajar et al., 2013). Due to these inconsistencies, it is neither 
possible to draw conclusions about whether low vitamin D levels are related to frailty as an 
overall-concept (which might include more than just the sum of the individual components) 
nor to generalize conclusions about the driving factors of the association. 
We may have found less associated frailty components than some other studies (Hirani 
et al., 2013; Tajar et al., 2013) due to the presence of depression in our sample.  Since 
depression and frailty are thought to be reciprocally associated (Collard et al., 2015b; Lakey 
et al., 2012), frailty prevalence rates are expected to be higher within a depressed population. 
In our sample the frailty rate was 29.9%, whereas in community-dwelling populations this 
rate was 9.9% (Collard, Boter, Schoevers, & Oude Voshaar, 2012). Furthermore, depression 
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has been associated with lower vitamin D levels in our population (Oude Voshaar et al., 
2014), and other populations (Anglin et al., 2013). Therefore, an association between vitamin 
D levels and frailty (and its components) might be harder to detect in a depressed sample.  
Since frailty had remitted in half of the baseline-frail participants, our longitudinal 
data underline that frailty is a dynamic process, as previously stated in a frailty consensus 
paper (Morley et al., 2013). In our depressed population, this dynamism might be partly 
confounded by overlap between frailty and depression (Lohman, Dumenci, & Mezuk, 2016). 
Nevertheless, the impact of vitamin D on the improvement of frailty was independent of 
depression status at follow-up.  
In line with our finding, a recent meta-analysis of seven longitudinal studies showed a 
pooled odds ratio of 1.27 (95%-CI 1.17 – 1.38) for incident frailty for lowest vitamin D levels 
(Zhou et al., 2016). Potential mechanisms explaining this prospective association include 1) 
the development of sarcopenia and muscle weakness, due to regulatory effects of vitamin D 
on calcium and mineral homeostasis and protein signaling pathways (Bruyère et al., 2017), 2) 
secondary hyperparathyroidism, caused by low 1,25 OH2 vitamin D and low calcium, leading 
to decreased bone mineralization and increased bone resorption, thus increasing fracture risk 
(Bruyère et al., 2017; Lips, 2006), and finally 3) the possible involvement of vitamin D 
deficiency in inflammation and activation of the immune system, which might play a role in 
the pathogenesis of auto-immune diseases and the development of frailty (Arnson, Amital, & 
Shoenfeld, 2007; Bruyère et al., 2017; Lips, 2006).  
In our sample, lower vitamin D levels at baseline predicted a decrease of physical 
activity at follow up. In other, population-based samples, low vitamin D levels were 
associated with physical inactivity/low energy expenditure as well as slowness (Shardell et 
al., 2009; Vogt et al., 2015) or none of the individual frailty criteria (Ensrud et al., 2010).  
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The presence of depression might explain why the association between low vitamin D 
levels and decrease of physical activity stands out. Previously, low vitamin D levels were 
suggested to be a marker of poor health in our sample (Van den Berg et al., 2016). Since poor 
health might add to increasing physical inactivity over time, and depression itself can also 
cause physical inactivity (Hiles, Lamers, Milaneschi, & Penninx, 2017), this might have 
amplified the association in our sample.  
In line with our unexpected finding of an association between lower vitamin D levels 
and remission of frailty, the population-based InChianti study (Shardell et al., 2012) also 
reported baseline frail participants with low vitamin D levels to be more likely to transit to 
pre-frailty (the presence of only 1 or 2 frailty criteria) at follow up. Despite this replication, 
our finding might still be considered a chance finding, due to the small sample of baseline 
frail persons (n=62). Confounding by indication (vitamin D supplementation in frail persons) 
is less likely, since we excluded persons using supplementation at follow-up. Intermittent 
supplementation during the follow-up period is unlikely to result in the strong effects we 
found.  
A third possibility is residual confounding, since a reciprocal association between 
frailty and depression exists (Collard et al., 2015b; Lakey et al., 2012;). Symptoms of 
depression might lead to a false-positive diagnosis of frailty, as the operational criteria of 
depression and frailty identify overlapping subpopulations (Mezuk, Edwards, Lohman, Choi, 
& Lapane, 2012; Mezuk, Lohman, Dumenci, & Lapane, 2013). However, this does not fit 
with our finding that the effect of vitamin D levels on frailty is not moderated by an effect of 
vitamin D on remission of depression.  
At last, a more plausible explanation might be that inactive behavior due to depression 
might lead to lower vitamin D levels. Upon remission of depression, frailty status also 
improves (partly due to overlap/confounding with depression, partly true improvement), while 
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vitamin D levels can stay behind. In our baseline-frail subgroup, depression had remitted 
significantly more often in participants with remitted frailty at follow up, than in the 
persistently frail.  
Nonetheless, taken into account that hitherto two studies reported this unexpected 




First, a dichotomous outcome measure for frailty has been used, and pre-frailty was not taken 
into account. Second, we did not have access to causes of death. Being able to include only 
people who died from frailty-related causes in the sensitivity analyses would have led to more 
accuracy. Now sensitivity analyses are likely an overestimation, and primary analyses an 
underestimation of the effect. Last, vitamin D levels were measured at baseline only. 
However, vitamin D levels seem to be relatively consistent over time (Jorde et al., 2010)49.  
 
Conclusion / clinical implications 
In our depressed population, like in community-based populations, lower vitamin D levels 
were associated with greater prevalence and incidence of frailty.  Future studies should 
examine whether the favorable effect of low vitamin D levels on the course of frailty can 
simply be explained by confounding or whether unknown pathophysiological mechanisms 
may exert protective effects. This is highly relevant, as vitamin D supplementation is 
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Table 1. Baseline characteristics, stratified by baseline frailty status. 
 
Characteristic Non-frail (n = 250) Frail (n = 102) Statistic 
Age (years); mean (sd) 69.7 (6.9) 73.2 (8.1) T -3.83, df 163.8, p <.001 
Female sex; n (%) 159 (63.6%) 72 (70.6%) 2 1.57, df 1, p .210 
Years of education; mean (sd) 10.9 (3.5) 9.7 (3.3) T 2.98, df 350, p .003 
Currently smoking; n (%) 65 (26.0%) 24 (23.5%) 2 0.166, df 1, p .683 
Alcohol usage (AUDIT sum 
score, 0-40); median (IQR) 
2.0 (4.0) 1.0 (3.0) Mann-Whitney U p .003 
Renal function (CKD-EPI, 
ml/min/1.73m2); mean (sd) 
72.6 (14.8) 69.7 (17.3) T 1.55, df 350, p .123 
Number of chronic diseases; 
mean (sd) 
2.3 (1.5) 3.0 (1.8) T -3.63, df 348, p <.001 
Severity of depression (IDS-
SR score, 0-84); mean (sd) 
26.6 (11.9) 37.3 (12.4) T-7.53, df 348, p <.001 
Cognitive functioning 
(MMSE score 0-30); median 
(IQR) 
28.0 (2.0) 28.0 (3.0) Mann-Whitney U p .005 
25-(OH) vitamin D (nmol/l); 
mean (sd) 
56.1 (22.7) 43.9 (21.6) T -2.81, df 350, p .005 
Season of blood withdrawal   2 9.19, df 3, p .027 
- Winter; n(%) 41 (16.4%) 28 (27.5%)  
- Spring; n(%) 70 (28.0%) 33 (32.4%) 2 0.66, df 1, p .415 
- Summer; n(%) 76 (30.4%) 26 (25.5%) 2 0.85, df 1, p .357 
- Autumn; n(%) 63 (25.2%) 15 (14.7%) 2 4.63, df 1, p .032 
Bold = statistical significance (p≤.050) 
Abbreviations: sd = standard deviation; IQR: interquartile range; df: degrees of freedom, AUDIT: Alcohol 
Use Disorders Identification Test; CKD-EPI: Chronic Kidney Disease Epidemiology Collaboration; IDS-





Table 2. Cross-sectional association of standardized vitamin D levels and prevalence of frailty 





(n = 352) 
Individual frailty components 
Slowness* 
 
(n = 349) 
Exhaustion 
 
(n = 344) 
Physical 
inactivity 
(n = 343) 
Weakness 
 
(n = 352) 
Weight 
loss 
(n = 352) 














0.53 [0.40–0.70]  
p < .001 
-0.07 (0.02) 
p .002 


























Bold = statistical significance (p≤.050) 
Abbreviations: OR = odds ratio, 95%-CI = 95%-confidence interval, B = Beta, se = standard 
error.  
* logtransformed 
†Covariates in final model: sexe, age, level of education, severity of depressive 
symptomatology, number of chronic diseases, cognitive functioning, renal function, smoking 
status, use of alcohol, season of blood withdrawal.  
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Table 3. Association of standardized vitamin D levels and incidence of frailty and change of 











(n = 182) 
 
Individual frailty components 
Slowness* 
 
(n = 172) 
Exhaustion 
 
(n = 173) 
Physical 
inactivity 
(n = 173) 
Weakness 
 






















vitamin D  
0.58  















































Bold = statistical significance (p≤.050) 
Abbreviations: OR = odds ratio, 95%-CI = 95%-confidence interval, B = Beta, se = standard 
error.  
* logtransformed 
†Covariates in final model: sexe, age, level of education, severity of depressive 
symptomatology, number of chronic diseases, cognitive functioning, renal function, smoking 
status, use of alcohol, season of blood withdrawal  
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Table 4. Association of vitamin D levels (standardized) and persistence of frailty and change 











(n = 75) 
 
Individual frailty components 
Slowness* 
 
(n = 62) 
Exhaustion 
 
(n = 61) 
Physical 
inactivity 
(n = 62) 
Weakness 
 









































































Bold = statistical significance (p≤.050) 
Abbreviations: OR = odds ratio, 95%-CI = 95%-confidence interval, B = Beta, se = standard 
error.  
* logtransformed 
†Covariates in final model: gender, age, level of education, severity of depressive 
symptomatology, number of chronic diseases, cognitive functioning, renal function, smoking 
status, use of alcohol, season of blood withdrawal 
 
